Karen Spilizewski is a Managing Director at RiverVest Venture Partners, focusing on early-stage medical device technologies. She joined in 2008, previously worked at BioEnterprise and Avery Dennison, and holds degrees from Case Western Reserve University.
At firms with a similar stage, sector and check size.
One email when Karen's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckKaren Spilizewski is a Managing Director at RiverVest Venture Partners, focusing on early-stage medical device technologies. She joined in 2008, previously worked at BioEnterprise and Avery Dennison, and holds degrees from Case Western Reserve University.
Karen Spilizewski invests through RiverVest, which writes checks of $3M to $30M at pre-seed, seed, series a, series b.
Email [email protected], the firm's inbox for founders, and name Karen in the subject. A warm intro from a founder RiverVest backed works better.
Avery Dennison Corporation; vice president at BioEnterprise; Avery Dennison Corporation.
Last updated 2026-10-15. Is this you? Ask for a correction.